Comparaisons Financières Intellia Therapeutics, Inc.
Actions
NTLA
US45826J1051
Recherche biotechnologique et médicale
|
Temps réel estimé
Cboe BZX
15:38:23 01/09/2026
|
Varia. 5j. | Varia. 1 janv. | ||
| 12,38 USD | -2,79% |
|
+1,35% | +41,60% |
| 06/08 | Transcript : Intellia Therapeutics, Inc., Q2 2026 Earnings Call, Aug 06, 2026 | |
| 06/08 | Intellia Therapeutics, Inc. : Wedbush maintient sa recommandation neutre | ZM |
Principaux concurrents
Ajouter à une liste 0 sélectionné | Chiffre d'affaires (N-1) | Marge nette (N-1) | Marge EBIT (N-1) | ROE (N-1) | ROA (N-1) | Leverage (N-1) | |
|---|---|---|---|---|---|---|---|
 | 67,67 M | -609,85% | -651,67% | -61,47% | -49,01% | 1.4x | |
| 8,24 Md | 14,53% | 21,7% | 10,28% | 4,9% | 1.58x | |
| 16,31 Md | 8,34% | 13,38% | 32,9% | 4,79% | 3.63x | |
| 5,34 Md | 5,37% | 8,37% | 29,84% | 16,27% | -5.99x | |
| 2,88 Md | 24,74% | 28,07% | 5,94% | 4,75% | 1.77x | |
| 2,53 Md | 17,83% | 20,93% | 70,23% | 22,13% | -0.89x | |
| 846 M | -31,67% | -18,92% | - | - | 1.57x | |
| 8,57 Md | 6,51% | 14,79% | 9,61% | 4,34% | 2.22x | |
| 4,02 Md | -3,59% | 19,77% | 15,46% | 6,99% | 1.98x | |
| 8,25 Md | 2,78% | 16,66% | 10,62% | 6,02% | 1.8x | |
| 1,27 Md | -19,27% | -3,71% | -38,64% | -6,61% | -65.61x | |
| 1,22 Md | 14,97% | 31,77% | 15,06% | 11,79% | -0.15x | |
| 2,02 Md | 11,8% | 13,68% | 11,6% | 6,52% | 1.83x | |
| 5,4 M | -7 306,52% | -5 350% | -135,58% | - | 2.1x | |
| 944 M | -40,36% | -40,47% | -70,72% | -11,67% | 4.51x | |
| 39,21 M | -794,04% | -891,07% | -25,78% | -22,89% | 4.75x | |
| 960 M | -55,53% | 26,46% | -12,87% | -10,52% | -0.45x | |
| Moyenne | 3,74 Md | -514,94% | -396,49% | -8,34% | -0,81% | -2,59x | |
| Moyenne pondérée par Capi. | 5,79 Md | -269,02% | -197,84% | 7,41% | 5,1% | -1,49x |
- Bourse
- Actions
- Action NTLA
- Secteur Intellia Therapeutics, Inc.
- Comparaisons Financières
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
